Novo Nordisk follows Eli Lilly to lower insulin prices next year

/ rivagreenberg

Today’s Wall Street Journal article, “Novo Nordisk to Slash Insulin Prices by Up to 75%” lets us know that come January 2024 Novo will reduce the cost of its popular rapid-acting Novolog by 75% and Novolin and Levemir by 65%. This follows Eli Lilly’s price reduction scheduled for later this year.

So, Sanofi what about you?

2 thoughts on “Novo Nordisk follows Eli Lilly to lower insulin prices next year”

  1. Pingback: Novo Nordisk follows Eli Lilly to decrease insulin costs subsequent 12 months - KaihanSaffron

  2. Pingback: Novo Nordisk follows Eli Lilly to lower insulin prices next year – GenkiWellness.com

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s